NCT05087615 - Effects of Ondansetron, Metoclopramide and Granisetron on Perioperative Nausea and Vomiting in Patients Undergone Bariatric Surgery | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

March 1, 2021

Primary Completion Date

August 21, 2021

Study Completion Date

September 6, 2021

Conditions

Bariatric Surgery CandidatePerioperative ComplicationNauseaVomiting, PostoperativeDrug Effect

Interventions

DRUG

Metoclopramide

This groups only received metoclopramide 0.2 mg/kg IV Bid as antiemetic in the postoperative period.

DRUG

Ondansetron

This groups only received ondansetron 8 mg IV Bid as antiemetic in the postoperative period.

DRUG

Metoclopramide and Ondanteron

This groups received both metoclopramide 0.2 mg IV Bid and ondansetron 8 mg IV/Bid as antiemetics in the postoperative period.

DRUG

Granisetron

This groups only received granisetron 2 mg IV Bid as antiemetic in the postoperative period.

Trial Locations (1)

Loghman Hakim Hospital, Tehran

All Listed Sponsors

lead

Shahid Beheshti University of Medical Sciences

OTHER